Sign In to Follow Application
View All Documents & Correspondence

Pharmaceutical Composition For Treating And/Or Preventing Cancer

Abstract: A conjugate, in which an antibody or a fragment thereof having immunological reactivity with a CAPRIN-1 protein that has an amino acid sequence represented by any one of the even numbered SEQ ID NOS: 2 to 30 or an amino acid sequence having 80% or more sequence identity with the aforesaid amino acid sequence is linked to a benzodiazepine, is useful as an antibody-drug conjugate (ADC).

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
06 December 2024
Publication Number
1/2025
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

TORAY INDUSTRIES, INC.
1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo 1038666

Inventors

1. OKANO Fumiyoshi
c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa 2488555
2. SAITO Takanori
c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa 2488555

Specification

Documents

Application Documents

# Name Date
1 202417096521-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-12-2024(online)].pdf 2024-12-06
2 202417096521-STATEMENT OF UNDERTAKING (FORM 3) [06-12-2024(online)].pdf 2024-12-06
5 202417096521-Sequence Listing in PDF [06-12-2024(online)].pdf 2024-12-06
6 202417096521-REQUEST FOR EXAMINATION (FORM-18) [06-12-2024(online)].pdf 2024-12-06
7 202417096521-PROOF OF RIGHT [06-12-2024(online)].pdf 2024-12-06
8 202417096521-POWER OF AUTHORITY [06-12-2024(online)].pdf 2024-12-06
9 202417096521-FORM 18 [06-12-2024(online)].pdf 2024-12-06
10 202417096521-FORM 1 [06-12-2024(online)].pdf 2024-12-06
11 202417096521-DECLARATION OF INVENTORSHIP (FORM 5) [06-12-2024(online)].pdf 2024-12-06
12 202417096521-COMPLETE SPECIFICATION [06-12-2024(online)].pdf 2024-12-06
13 202417096521-certified copy of translation [09-12-2024(online)].pdf 2024-12-09
14 202417096521-MARKED COPIES OF AMENDEMENTS [18-12-2024(online)].pdf 2024-12-18
15 202417096521-FORM 13 [18-12-2024(online)].pdf 2024-12-18
16 202417096521-AMMENDED DOCUMENTS [18-12-2024(online)].pdf 2024-12-18
17 202417096521-FORM 3 [30-05-2025(online)].pdf 2025-05-30